EFFICACY AND SAFETY OF HIGHER vs LOWER DOSE ADALIMUMAB MAINTENANCE THERAPY AS A FUNCTION OF DISEASE SEVERITY IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE:
